國立虎尾科技大學 |

Biologics to Treat Substance Use Disorders = Vaccines, Monoclonal Antibodies, and Enzymes /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Biologics to Treat Substance Use Disorders/ edited by Ivan D. Montoya.
Reminder of title:	Vaccines, Monoclonal Antibodies, and Enzymes /
other author:	Montoya, Ivan D.
Description:	XVI, 453 p. 104 illus., 57 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Psychopharmacology. -
Online resource:	https://doi.org/10.1007/978-3-319-23150-1
ISBN:	9783319231501

Biologics to Treat Substance Use Disorders = Vaccines, Monoclonal Antibodies, and Enzymes /
Biologics to Treat Substance Use DisordersVaccines, Monoclonal Antibodies, and Enzymes /[electronic resource] :edited by Ivan D. Montoya. - 1st ed. 2016. - XVI, 453 p. 104 illus., 57 illus. in color.online resource.

Introduction -- PART I: Vaccines: Introduction -- Nicotine -- Cocaine -- Heroin -- Metamphetamine -- PART II: Monoclonal antibodies: Introduction -- Cocaine -- Metamphetamine -- PCP -- PART III: Enzymes: Introduction -- Butyrylcholinesterase -- Cocaine Esterase -- PART IV: New strategies to optimize the development of biologics: Adenovirus based vaccines -- Nanotechnology based vaccines -- Protein Nanoparticles -- DNA Scaffolded Vaccines -- Single Hapten Conjugate Therapeutic Vaccine -- Vaccine Adjuvants -- Laser Adjuvant -- Peptide Conjugates & Cytokine Adjuvants -- T. brucei: A Platform for Immunization -- Vaccines for SUDs and HIV infection -- New Monoclonal Antibodies -- Protein Engineered for Controlled Duration of Action -- PART V: Ethical aspects of biologics to treat SUDs.

This book is a scientific compendium documenting the state of the art in the discovery and development of vaccines, monoclonal antibodies, and enzymes for the treatment of Substance Use Disorders (SUDs). The book gives detailed consideration to some of the most cutting edge topics in addiction medicine, including vaccines for nicotine, cocaine, heroin, and methamphetamine dependence; monoclonal antibodies against cocaine, methamphetamine, and phencyclidine; and the enzymes butyrylcholinesterase and cocaine esterase. In addition, the text covers a wide range of new strategies designed to optimize the development and efficacy of biologics. Unlike any other resource, this book reviews how biologics offer exciting new therapeutic opportunities for various psychiatric conditions. Written by experts in the field, Biologics to Treat Substance Use Disorders is as an authoritative reference for psychiatrists, psychologists, and all other medical professionals working with patients suffering from Substance Use Disorders.

ISBN: 9783319231501

Standard No.: 10.1007/978-3-319-23150-1doiSubjects--Topical Terms:

644799
Psychopharmacology.

LC Class. No.: RM315-334

Dewey Class. No.: 615.78

Biologics to Treat Substance Use Disorders = Vaccines, Monoclonal Antibodies, and Enzymes /
LDR:03190nam a22003975i 4500 001 979880
003 DE-He213
005 20200629203346.0
007 cr nn 008mamaa
008 201211s2016 gw | s |||| 0|eng d
020 $a 9783319231501 $9 978-3-319-23150-1
024 7 $a 10.1007/978-3-319-23150-1 $2 doi
035 $a 978-3-319-23150-1
050 4 $a RM315-334
072 7 $a MMGW $2 bicssc
072 7 $a MED105020 $2 bisacsh
072 7 $a MKGW $2 thema
082 0 4 $a 615.78 $2 23
245 1 0 $a Biologics to Treat Substance Use Disorders $h [electronic resource] : $b Vaccines, Monoclonal Antibodies, and Enzymes / $c edited by Ivan D. Montoya.
250 $a 1st ed. 2016.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a XVI, 453 p. 104 illus., 57 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Introduction -- PART I: Vaccines: Introduction -- Nicotine -- Cocaine -- Heroin -- Metamphetamine -- PART II: Monoclonal antibodies: Introduction -- Cocaine -- Metamphetamine -- PCP -- PART III: Enzymes: Introduction -- Butyrylcholinesterase -- Cocaine Esterase -- PART IV: New strategies to optimize the development of biologics: Adenovirus based vaccines -- Nanotechnology based vaccines -- Protein Nanoparticles -- DNA Scaffolded Vaccines -- Single Hapten Conjugate Therapeutic Vaccine -- Vaccine Adjuvants -- Laser Adjuvant -- Peptide Conjugates & Cytokine Adjuvants -- T. brucei: A Platform for Immunization -- Vaccines for SUDs and HIV infection -- New Monoclonal Antibodies -- Protein Engineered for Controlled Duration of Action -- PART V: Ethical aspects of biologics to treat SUDs.
520 $a This book is a scientific compendium documenting the state of the art in the discovery and development of vaccines, monoclonal antibodies, and enzymes for the treatment of Substance Use Disorders (SUDs). The book gives detailed consideration to some of the most cutting edge topics in addiction medicine, including vaccines for nicotine, cocaine, heroin, and methamphetamine dependence; monoclonal antibodies against cocaine, methamphetamine, and phencyclidine; and the enzymes butyrylcholinesterase and cocaine esterase. In addition, the text covers a wide range of new strategies designed to optimize the development and efficacy of biologics. Unlike any other resource, this book reviews how biologics offer exciting new therapeutic opportunities for various psychiatric conditions. Written by experts in the field, Biologics to Treat Substance Use Disorders is as an authoritative reference for psychiatrists, psychologists, and all other medical professionals working with patients suffering from Substance Use Disorders.
650 0 $a Psychopharmacology. $3 644799
650 0 $a Pharmacotherapy. $3 973587
650 0 $a Pharmacology. $3 583819
650 2 4 $a Pharmacology/Toxicology. $3 593882
700 1 $a Montoya, Ivan D. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1104293
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319231495
776 0 8 $i Printed edition: $z 9783319231518
776 0 8 $i Printed edition: $z 9783319794518
856 4 0 $u https://doi.org/10.1007/978-3-319-23150-1
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)